Contraindications and Who Should Avoid Oral GLP-1 Oral semaglutide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2), as GLP-1 agonists may theoretically increase thyroid C-cell proliferation
Gut barrier disruption and chronic disease
HSA/FSA : If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can use those funds to pay for semaglutide
BG: Writing review and editing, Methodology
2001, url: Rehman J, Benet A, Melman A
In the hypothalamus, the 5-HT1B receptors are expressed by the NPY/AgRP neurons and their activation inhibits the release of GABA, thus disinhibiting the anorexigenic system, inducing appetite suppression (Figure 1)